ArticleMikrochimica acta2025
Imaging lipid deposition induced by local hypoxia in degenerative aortic valve disease using a twisted intramolecular charge transfer (TICT)-based lipid droplet-targeting probe.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
A novel twisted intramolecular charge transfer (TICT)-based fluorescent probe, NMCTI, specifically engineered for selective visualization of lipid droplets (LDs) under hypoxic pathological conditions was developed. NMCTI exhibited an impressive Stokes shift of 112 nm, substantial solvatochromic fluorescence properties, and minimal cytotoxic effects. In cellular experiments, NMCTI demonstrated selective targeting and accumulation within LDs in HeLa cells, HUVECs and HL-1 mouse cardiomyocytes (HL-1 cells), accompanied by outstanding photostability, enabling clear and robust visualization of LDs under hypoxic conditions. Additionally, ex vivo imaging experiments on human valve tissues confirmed NMCTI's capability to clearly highlight lipid deposits in stenotic aortic valves. The imaging results were consistent with traditional histological staining, effectively differentiating pathological valves from healthy controls. These findings indicate that NMCTI can serve as a highly effective fluorescent imaging tool, significantly enhancing the detection and understanding of lipid accumulation in cardiovascular diseases, thereby contributing to improved diagnostic accuracy and therapeutic approaches for degenerative aortic valve disease (DAD).
Indexed as
Identifiers
41107664What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.